258 related articles for article (PubMed ID: 9134999)
1. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
2. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
Zhang T; Nanney LB; Luongo C; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 Jan; 57(1):169-75. PubMed ID: 8988060
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts.
Ravitz MJ; Yan S; Dolce C; Kinniburgh AJ; Wenner CE
J Cell Physiol; 1996 Sep; 168(3):510-20. PubMed ID: 8816905
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.
Ko TC; Sheng HM; Reisman D; Thompson EA; Beauchamp RD
Oncogene; 1995 Jan; 10(1):177-84. PubMed ID: 7824270
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cyclin D1 and CDK expression in colonic polyps containing neoplastic foci: a study of proteins extracted from paraffin sections.
Izawa H; Yamamoto H; Ikeda M; Ikeda K; Fukunaga H; Yasui M; Ikenaga M; Sekimoto M; Monden T; Matsuura N; Monden M
Oncol Rep; 2002; 9(6):1313-8. PubMed ID: 12375040
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells.
Sheng H; Shao J; Hooton EB; Tsujii M; DuBois RN; Beauchamp RD
Cell Growth Differ; 1997 Apr; 8(4):463-70. PubMed ID: 9101092
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D
Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588
[TBL] [Abstract][Full Text] [Related]
9. Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations.
Grady WM; Willis JE; Trobridge P; Romero-Gallo J; Munoz N; Olechnowicz J; Ferguson K; Gautam S; Markowitz SD
Int J Cancer; 2006 Feb; 118(3):600-8. PubMed ID: 16108056
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
11. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
12. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
Ando K; Griffin JD
Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
[TBL] [Abstract][Full Text] [Related]
13. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
[TBL] [Abstract][Full Text] [Related]
14. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
[TBL] [Abstract][Full Text] [Related]
18. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.
Melnick M; Chen H; Buckley S; Warburton D; Jaskoll T
Dev Dyn; 1998 Jan; 211(1):11-25. PubMed ID: 9438420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
